{'fraction_non_alphanumeric': 0.02448210922787194, 'fraction_numerical': 0.003138731952291274, 'mean_word_length': 4.692857142857143, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A review regarding virology, etiology, prevalence and associated risk factors of Hepatitis A.

Hepatitis A is an infectious disorder of the liver prompted by Hepatovirus A virus (HAV). It is a kind of viral hepatitis. It has naked nucleocapsid virus with a single stranded, positive polarity RNA. It is devoid of virion polymerase and has a single serotype. Transmission is via fecal–oral route. In contrast to Hepatitis B virus and Hepatitis C virus, blood borne transmission of HAV is infrequent because viremia is short-term and of low titer. Mostly instances, have few or no signs, specifically in younger ones. The virus replicates in the gastrointestinal tract and then spreads to the liver during a short-term viremic period. HAV is not cytopathic for the hepatocyte. Hepatocellular injury is triggered by immune attack by the cytotoxic T cells. The time among the infection and signs, in patients that progress them, is among two and six weeks. When the signs occur, they commonly last 8 weeks and might encompass nausea, vomiting, diarrhea, jaundice, pain in abdomen and fever. Around 10 to 15 percent of patients undergo a recurrence of signs at some stage in the six months after the preliminary infection. Acute liver failure may also seldom occur, with this being extra regular in elderly. No antiviral medication is available. The most suitable test to diagnose acute infection is IgM antibody. Isolation of the virus from clinical samples is not done. Vaccine consists of killed virus. Administration of immune globulin in the course of the incubation can alleviate the disease.